Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

UK doctors call on NHS to use Avastin for wet AMD

UK doctors call on NHS to use Avastin for wet AMD Currently, GMC guidance and European drug licensing laws say that Lucentis (ranibizumab), from Novartis and Roche, and Bayer/Regeneron's Eylea(aflibercept) - that are approved to treat wet AMD - should be ... Eylea because it is around a tenth of the

NICE recommends Ozurdex for diabetic eye condition

NICE recommends Ozurdex for diabetic eye condition d Eylea (aflibercept), which both have licences for DMO.

Fresh approval for Roche's Lucentis as competition heats up

Fresh approval for Roche's Lucentis as competition heats up Roche's drug is being challenged in the market by Bayer's Eylea (aflibercept) as well as newer entrants such as Allergan's Ozurdex (intravitreal dexamethasone).

Novartis launches another localised NHS eye service in UK

Novartis launches another localised NHS eye service in UK The drug was the dominant force in wet AMD treatment for some time, although is now facing a challenge from Bayer's Eylea (aflibercept), which was recommended in 2013. ... The update was significant for Novartis as Eylea is recommended as a monthly

Germany's IQWiG delivers bad news for Bayer’s Eylea

Germany's IQWiG delivers bad news for Bayer’s Eylea Germany's cost-effectiveness watchdog has concluded that Bayer's Eylea provides no additional benefit over Novartis' rival drug Lucentis in patients with a diabetes-related eye disorder. ... The ruling could mean Bayer may struggle to get favourable

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...